Hyman B. Muss, MD, professor of oncology, University of North Carolina, director, Geriatric Oncology, Lineberger Comprehensive Cancer Center, discusses optimizing adjuvant treatment in older patients with breast cancer.

Muss says the average age of breast cancer patient in the US is 61 and the majority of women who don’t survive breast cancer are 65 and older. Older breast cancer patients typically do not qualify for clinical trials due to their age or comorbidities.

Comorbidities also make it difficult to treat these patients and may even be more serious than their breast cancer. Muss says the goal of treating these patients is to understand their functional status, talk to them about their goals, and help them maintain the highest quality of life possible.

View more from the 32nd Annual Miami Breast Cancer Conference

Conference

® Conference page includes a listing of all conferences covered by 

, including the ASCO, ESMO, SITC, EHA, ASH, and SABCS annual meetings, as well as the Chemotherapy Foundation Symposium and Miami Breast Cancer Conference, among many others. Conference coverage incorporates articles and interviews in written and video format.


Breast Cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Dr. Muss on Optimizing Adjuvant Treatment for Older Breast Cancer Patients